Evidence map›Paper›PMID 33460486›Full record

ArticleEuropean journal of neurology2021

A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.

Johann Sellner, Thomas M Jenkins, Tim J von Oertzen, Claudio L Bassetti, Ettore Beghi, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, Giovanni Di Liberto, Raimund Helbok and 16 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 13 countries.

Johann SellnerDepartment of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria.ORCID 0000-0001-8749-5533
Thomas M JenkinsSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Tim J von OertzenFaculty of Medicine, Johannes-Kepler Universität, Linz, Austria.ORCID 0000-0003-2164-7842
Claudio L BassettiDepartment of Neurology, Inselspital, University of Bern, Bern, Switzerland.ORCID 0000-0002-4535-0245
Ettore BeghiIstituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy.ORCID 0000-0003-2542-0469
Daniel BereczkiDepartment of Neurology, Semmelweis University, Budapest, Hungary.ORCID 0000-0002-8374-0500
Benedetta BodiniDepartment of Neurology, Saint-Antoine Hospital, APHP, Sorbonne University, Paris, France.
Francesco CavallieriNeurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Giovanni Di LibertoDepartment of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
Raimund HelbokDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-5682-0145
Antonella MacerolloWalton Centre NHS Foundation Trust, Liverpool, UK.
Luis F MaiaDepartment of Neurology, Hospital Santo António, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Celia Oreja-GuevaraDepartment of Neurology, Hospital Clinico San Carlos, Madrid, Spain.
Serefnur ÖzturkDepartment of Neurology, Faculty of Medicine, Selcuk University, Konya, Turkey.
Martin RakusaDepartment of Neurology, University Medical Centre Maribor, Maribor, Slovenia.ORCID 0000-0003-4433-3985
Antonio PisaniDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Alberto PrioriDivision of Neurology, Department of Neurology, 'Aldo Ravelli' Research Center, University of Milan and ASST Santi Paolo e Carlo, Milan, Italy.ORCID 0000-0002-1549-3851
Anna SauerbierDepartment of Neurology, University Hospital Cologne, Cologne, Germany.
Riccardo SoffiettiDivision of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy.
Pille TabaDepartment of Neurology and Neurosurgery, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.ORCID 0000-0002-5439-1022
Marialuisa ZeddeNeurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Michael CreanEuropean Academy of Neurology (EAN) Head Office, Vienna, Austria.
Anja BurlicaEuropean Academy of Neurology (EAN) Head Office, Vienna, Austria.
Alex TwardzikEuropean Academy of Neurology (EAN) Head Office, Vienna, Austria.
Elena MoroDivision of Neurology, CHU of Grenoble, Grenoble Institute of Neurosciences, Grenoble Alpes University, Grenoble, France.
EAN NeuroCOVID-19 Task Force
European Academy of Neurology · ATUniversity of Modena and Reggio Emilia · ITAOL (United States) · USCentre Hospitalier Universitaire de Grenoble · FRi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTInnsbruck Medical University · ATJohannes Kepler University of Linz · ATKing's College Hospital NHS Foundation Trust · GBMario Negri Institute for Pharmacological Research · ITNeuroscience Institute · ITParacelsus Medical University · ATSelçuk University · TRSemmelweis University · HUSheffield Teaching Hospitals NHS Foundation Trust · GBSorbonne Université · FRUniversidad Complutense de Madrid · ESUniversity Clinical Centre Maribor · SIUniversity Hospital of Lausanne · CHUniversity of Bern · CHUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), a multi-organ disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to challenge health and care systems around the globe. The pandemic has disrupted acute neurology services and routine patient care and has impacted the clinical course in patients with chronic neurological disease. COVID-19 appears to have exposed inequalities of societies and healthcare systems and had a disproportionate impact on already vulnerable communities. The next challenge will be to set up initiatives to stop disparities in all aspects related to COVID-19. From the medical perspective, there is a need to consider inequalities in prevention, treatment and long-term consequences. Some of the issues of direct relevance to neurologists are summarised. With this appraisal, the European Academy of Neurology NeuroCOVID-19 Task Force intends to raise awareness of the potential impact of COVID-19 on inequalities in healthcare and calls for action to prevent disparity at individual, national and supranational levels.

Indexed as

COVID-19NeurologyHumansPandemicsSARS-CoV-2VaccinationadvocacyCOVID-19disparityequitable global healthneurologyprimary preventionSARS-CoV-2

Identifiers

PMID33460486
PMCPMC8014664
OpenAlexW3124822266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.